Decentralised clinical trials in multiple sclerosis research

Garjani, Afagh, Jun-Yu Liu, Brandon, Allen, Christopher Martin, Gunzler, Douglas David, Gerry, Stephen William, Planchon, Sarah Marie, das Nair, Roshan, Chataway, Jeremy, Tallantyre, Emma ORCID: https://orcid.org/0000-0002-3760-6634, Ontaneda, Daniel and Evangelou, Nikos 2023. Decentralised clinical trials in multiple sclerosis research. Multiple Sclerosis Journal 29 (3) , pp. 317-325. 10.1177/13524585221100401

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (316kB) | Preview

Abstract

Randomised controlled trials (RCTs) play an important role in multiple sclerosis (MS) research, ensuring that new interventions are safe and efficacious before their introduction into clinical practice. Trials have been evolving to improve the robustness of their designs and the efficiency of their conduct. Advances in digital and mobile technologies in recent years have facilitated this process and the first RCTs with decentralised elements became possible. Decentralised clinical trials (DCTs) are conducted remotely, enabling participation of a more heterogeneous population who can participate in research activities from different locations and at their convenience. DCTs also rely on digital and mobile technologies which allows for more flexible and frequent assessments. While hospitals quickly adapted to e-health and telehealth assessments during the COVID-19 pandemic, the conduct of conventional RCTs was profoundly disrupted. In this paper, we review the existing evidence and gaps in knowledge in the design and conduct of DCTs in MS.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher:	SAGE Publications
ISSN:	1352-4585
Date of First Compliant Deposit:	22 April 2022
Date of Acceptance:	19 April 2022
Last Modified:	03 Jun 2023 05:55
URI:	https://orca.cardiff.ac.uk/id/eprint/149298

Actions (repository staff only)

Edit Item